Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

61. Management of Women With Dense Breasts Diagnosed by Mammography

Management of Women With Dense Breasts Diagnosed by Mammography Management of Women With Dense Breasts Diagnosed by Mammography - ACOG Menu ▼ Management of Women With Dense Breasts Diagnosed by Mammography Page Navigation ▼ A correction was published in January 2016 for this title. Click to view the correction. Number 625, March 2015 (Reaffirmed 2019) Committee on Gynecologic Practice This document reflects emerging clinical and scientific advances as of the date issued and is subject to change (...) . The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Management of Women With Dense Breasts Diagnosed by Mammography ABSTRACT: Women with dense breasts have a modestly increased risk of breast cancer and experience reduced sensitivity of mammography to detect breast cancer. However, evidence is lacking to advocate for additional testing until there are clinically validated data that indicate improved screening outcomes. Currently, screening

2015 American College of Obstetricians and Gynecologists

62. Diagnostic performance of contrast-enhanced spectral mammography: systematic review and meta-analysis

Diagnostic performance of contrast-enhanced spectral mammography: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2015 PROSPERO

63. Systematic review of the value of breast MRI in combination with mammography versus mammography alone in screening for breast cancer in women at elevated risk

Systematic review of the value of breast MRI in combination with mammography versus mammography alone in screening for breast cancer in women at elevated risk Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2015 PROSPERO

64. Full-field digital mammography for breast cancer screening

Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Full-field digital mammography for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2015 (...) Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Humans; Mammography Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32016000106 Date abstract

2015 Health Technology Assessment (HTA) Database.

65. Use of Digital Breast Tomosynthesis with Mammography for Breast Cancer Screening or Diagnosis

Use of Digital Breast Tomosynthesis with Mammography for Breast Cancer Screening or Diagnosis Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) BlueCross BlueShield Association. Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 28(6). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasmss; Imaging, Three-Dimensional; Mammography; Mass Screening Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence

2014 Health Technology Assessment (HTA) Database.

66. Breast cancer screening using tomosynthesis in combination with digital mammography. Full Text available with Trip Pro

Breast cancer screening using tomosynthesis in combination with digital mammography. Mammography plays a key role in early breast cancer detection. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results.To determine if mammography combined with tomosynthesis is associated with better performance of breast screening programs in the United States.Retrospective analysis of screening performance metrics from 13 (...) academic and nonacademic breast centers using mixed models adjusting for site as a random effect.Period 1: digital mammography screening examinations 1 year before tomosynthesis implementation (start dates ranged from March 2010 to October 2011 through the date of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from initiation of tomosynthesis screening (March 2011 to October 2012) through December 31, 2012.Recall rate for additional imaging, cancer

2014 JAMA

67. Modern mammography screening and breast cancer mortality: population study. Full Text available with Trip Pro

Modern mammography screening and breast cancer mortality: population study. To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes.Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 (...) by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime.During 15 193 034 person years

2014 BMJ

68. Abolishing Mammography Screening Programs? A View from the Swiss Medical Board. Full Text available with Trip Pro

Abolishing Mammography Screening Programs? A View from the Swiss Medical Board. 24738641 2014 05 29 2016 11 25 1533-4406 370 21 2014 May 22 The New England journal of medicine N. Engl. J. Med. Abolishing mammography screening programs? A view from the Swiss Medical Board. 1965-7 10.1056/NEJMp1401875 Biller-Andorno Nikola N From the Institute of Biomedical Ethics, University of Zurich, Zurich (N.B.-A.), and the Institute of Social and Preventive Medicine and Clinical Trials Unit Bern, Department (...) Neoplasms diagnostic imaging mortality prevention & control Early Detection of Cancer ethics methods False Positive Reactions Female Humans Mammography ethics Switzerland Technology Assessment, Biomedical Unnecessary Procedures 2014 4 18 6 0 2014 4 18 6 0 2014 5 30 6 0 ppublish 24738641 10.1056/NEJMp1401875

2014 NEJM

69. Screening mammography in older women: a review. Full Text available with Trip Pro

Screening mammography in older women: a review. Guidelines recommend individualizing screening mammography decisions for women aged 75 years and older. However, little pragmatic guidance is available to help counsel patients.To provide an evidence-based approach for individualizing decision-making about screening mammography in older women.We searched PubMed for English-language studies in peer-reviewed journals published from January 1, 1990, to February 1, 2014, to identify risk factors (...) for late-life breast cancer in women aged 65 years and older and to quantify the benefits and harms of screening mammography for women aged 75 years and older.Age is the major risk factor for developing and dying from breast cancer. Breast cancer risk factors that reflect hormonal exposures in the distant past, such as age at first birth or age at menarche, are less predictive of late-life breast cancer than factors indicating recent hormonal exposures such as high bone mass or obesity. Randomized

2014 JAMA

70. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Full Text available with Trip Pro

Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Controversy exists over how often and at what age mammography screening should be implemented. Given that evidence supports less frequent screening, the cost differences among advocated screening policies should be better understood.To estimate the aggregate cost of mammography screening in the United States in 2010 and compare the costs of policy recommendations (...) by professional organizations.A model was developed to estimate the cost of mammography screening in 2010 and 3 screening strategies: annual (ages 40 to 84 years), biennial (ages 50 to 69 years), and U.S. Preventive Services Task Force (USPSTF) guidelines (biennial for those aged 50 to 74 years and personalized based on risk for those younger than 50 years and based on comorbid conditions for those 75 years and older).United States.Women aged 40 to 85 years.Mammography annually, biennially, or following

2014 Annals of Internal Medicine

71. Screening mammography program: physician protocol for screening mammograms

Screening mammography program: physician protocol for screening mammograms Screening Mammography Program Physician Protocol for Screening Mammograms risk policy rationale Average risk Ages 40-49 Health care providers are encouraged to discuss the benefits and limitations of screening mammography with asymptomatic women in this age group. If screening mammography is chosen, it is available every two years. Patients will be recalled every two years. A health care provider’s referral (...) in women ages 50 and older who have no risk factors other than being an aging female. Average risk Ages 75+ Health care providers are encouraged to discuss the benefits and limitations of screening mammography with asymptomatic women in this age group. Health care providers should discuss stopping screening when there are comorbidities associated with a limited life expectancy or physical limitations for mammography that prevent proper positioning. If screening mammography is chosen, it is available

2014 CPG Infobase

72. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) cancer risk factors between screened and unscreened women and what estimates are used when making these adjustments; the duration for which women are followed after screening cessation; the estimates used for lead-time effects (i.e., the time diagnosis was brought forward through screening); whether account is taken of non-diagnostic mammography outside the screening program and how this is done; death rates from other diseases and hence variations in life expectancy at time of screening; screening

2014 Cancer Australia

73. Double versus single reading of mammography for diagnosis in breast cancer screening programmes

Double versus single reading of mammography for diagnosis in breast cancer screening programmes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2014 PROSPERO

74. Systematic review of 3D mammography for breast cancer screening

Systematic review of 3D mammography for breast cancer screening Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2014 PROSPERO

75. Cost-effectiveness study: Estimating the cost-effectiveness of modern screening mammography programmes

Cost-effectiveness study: Estimating the cost-effectiveness of modern screening mammography programmes Estimating the cost-effectiveness of modern screening mammography programmes | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Estimating the cost-effectiveness of modern screening mammography programmes Article Text Economic analysis Cost-effectiveness study Estimating the cost-effectiveness of modern screening mammography programmes Jean-Luc

2014 Evidence-Based Medicine

76. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening

Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Computer (...) -aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2014 Authors' objectives Computer-aided detection (CAD) for breast cancer screening involves the use of computer-based algorithms to identify potentially malignant abnormalities in radiographic images, which may help to reduce mortality. The goals of using CAD are to minimize false-positives that lead to unnecessary diagnostic testing and to minimize false

2014 Health Technology Assessment (HTA) Database.

77. [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]

[Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review] Mammographie numérique de dépistage. Analyse critique de l'article de Chiarelli (2013) et revue de littérature [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review] Mammographie numérique de dépistage. Analyse critique de l'article de Chiarelli (2013) et revue de littérature [Digital screening mammography. Critical analysis (...) of the article by Chiarelli (2013) and literature review] Moqadem K, Boulanger J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Moqadem K, Boulanger J . Mammographie numérique de dépistage. Analyse critique de l'article de Chiarelli (2013) et revue de littérature . [Digital screening mammography. Critical analysis of the article by Chiarelli (2013

2014 Health Technology Assessment (HTA) Database.

78. Cohort study: Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results Full Text available with Trip Pro

Cohort study: Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results Article Text Aetiology Cohort study Some

2014 Evidence-Based Medicine

79. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Full Text available with Trip Pro

Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Breast cancer is the most common malignant disease diagnosed in women worldwide. Screening with mammography has the ability to detect breast cancer at an early stage. The diagnostic accuracy of mammography screening largely depends on the radiographic density of the imaged breasts. In radiographically dense breasts, non-calcified breast cancers are more likely (...) to be missed than in fatty breasts. As a consequence, some cancers are not detected by mammography screening. Supporters of adjunct ultrasonography to the screening regimen for breast cancer argue that it might be a safe and inexpensive approach to reduce the false negative rates of the screening process. Critics, however, are concerned that performing supplemental ultrasonography on women at average risk will also increase the rate of false positive findings and can lead to unnecessary biopsies

2013 Cochrane

80. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Full Text available with Trip Pro

Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Computer-aided detection (CAD) has rapidly diffused into screening mammography practice despite limited and conflicting data on its clinical effect.To determine associations between CAD use during screening mammography and the incidence of ductal carcinoma in situ (DCIS) and invasive breast cancer, invasive cancer stage, and diagnostic testing.Retrospective cohort (...) study.Medicare program.Women aged 67 to 89 years having screening mammography between 2001 and 2006 in U.S. SEER (Surveillance, Epidemiology and End Results) regions (409 459 mammograms from 163 099 women).Incident DCIS and invasive breast cancer within 1 year after mammography, invasive cancer stage, and diagnostic testing within 90 days after screening among women without breast cancer.From 2001 to 2006, CAD prevalence increased from 3.6% to 60.5%. Use of CAD was associated with greater DCIS incidence

2013 Annals of Internal Medicine